Prenatal alcohol effects on the gut microbiome contributing to failure to thrive and altered immune function
Prenatal alcohol effects on the gut microbiome contributing to failure to thrive and altered immune function
批准号:
9391802
负责人:
THOMAS G BLANCHARD
金额:
$11.22万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2019-05-31
关键词:
Actinobacteria classAddressAdoptedAdoptive TransferAdultAftercareAlcohol consumptionAlcoholsAnimalsBackBacteriaBacteroidetesBiological MarkersBirthCategoriesCellsChild health careColonConsensusDietDisadvantagedDiscipline of NursingDiseaseElementsEpithelial CellsFailure to ThriveFemaleFetal Alcohol Spectrum DisorderFetal alcohol effectsFoodFundingFutureGestational AgeGrowthHealthHeightHomeostasisHousingHumanHuman MicrobiomeImmuneImmune responseImmune systemImmunityImmunofluorescence ImmunologicImmunologicsImmunosuppressionIn VitroInfantInfluentialsIntestinesLarge IntestineLifeLymphocyteModelingMothersNatureNeonatalNewborn InfantNursesOralParentsPlayPopulationPopulation DynamicsPrevalenceProbioticsProductionRattusRegulatory T-LymphocyteResistanceRiskRodentRoleSamplingSmall IntestinesSocial InteractionSourceSpleenStudy SubjectSystems DevelopmentT cell responseT-LymphocyteTaxonomyTestingTherapeuticTimeTranslatingUnited States National Institutes of HealthWeaningalcohol exposurebasechronic alcohol ingestionclinical investigationcytokinedesignfecal transplantationgut microbiomegut microbiotahigh riskhuman subjectimmune functionimmunoregulationimprovedin uteromicrobiomemicrobiotaneonatenutritionoffspringpregnantpupresponsesocialsound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Fetal Alcohol Spectrum Disorder (FASD) can include growth deficiency that is not attributable to parental
height, gestational age, or poor nutrition. Recent studies on the gut microbiome indicate that perturbations in
the population dynamics of the gut bacteria early in life can have deleterious consequences on the host
including failure to thrive and other sequelae typically associated with poor nutrition throughout life. The impact
of an altered microbiota can negate efforts to overcome these deficiencies with improved nutrition. Alcohol
consumption has been demonstrated to alter the ratios of defined bacterial genera in adults. Since newborn
babies adopt the flora of the birth mother, it is likely that neonates at high risk for a FASD have an altered gut
microbiome that ultimately translates to poor nutrition given the importance of gut bacteria in processing certain
food products and generating dietary needs. Gut bacteria also play a crucial role in promoting immunologic
homeostasis. Alterations in bacterial populations may result in less down-regulatory IL-25 production by
epithelial cells and increased proinflammatory T cells. The role of the gut microbiome in FASD associated
immunological based diseases and failure to thrive has been understudied. We hypothesize newborn rats
exposed to alcohol in utero will develop altered gut microbiota upon delivery compared to control rat pups and
that this altered microbiota will contribute to delayed growth and immune dysregulation. To test this hypothesis
we propose to 1) Compare the gut microbiota of female rats before and after chronic consumption of alcohol,
and analyze the gut microbiota of their pups over time to determine if they adopt the flora of the mother.
Additionally, we will determine if the flora is distinct from that of pups born to control dams not receiving
alcohol. 2) Compare the intestinal immune features from pups exposed to alcohol in utero to control pups to
determine if alcohol exposure results in reduced regulatory immune system elements and an increase in
proinflammatory markers and T cells. 3) Identify bacterial profiles in the gut microbiota associated with failure
to thrive and/or immune dysregulation and determine if these conditions can be treated by therapeutic
application of probiotics designed to match the colonic flora of pups born to control dams. Future studies could
readily be applied to human subjects if these studies in animals provide a sound premise for clinical
investigation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project
-
批准号:10311912
-
项目类别:
-
资助金额:$335.0万
-
财政年份:2021
-
负责人:THOMAS G BLANCHARD
-
依托单位:
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to
-
批准号:7701567
-
项目类别:
-
资助金额:$30.33万
-
财政年份:2009
-
负责人:THOMAS G BLANCHARD
-
依托单位:
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
-
批准号:7021369
-
项目类别:
-
资助金额:$22.12万
-
财政年份:2004
-
负责人:THOMAS G BLANCHARD
-
依托单位:
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
-
批准号:7343179
-
项目类别:
-
资助金额:$17.76万
-
财政年份:2004
-
负责人:THOMAS G BLANCHARD
-
依托单位:
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
-
批准号:7173722
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2004
-
负责人:THOMAS G BLANCHARD
-
依托单位:
H. PYLORI- REGULATORY T CELLS THAT LIMIT HOST RESPONSE
-
批准号:6775044
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2004
-
负责人:THOMAS G BLANCHARD
-
依托单位:
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
-
批准号:7630113
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2004
-
负责人:THOMAS G BLANCHARD
-
依托单位:
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
-
批准号:6846053
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2004
-
负责人:THOMAS G BLANCHARD
-
依托单位:
Helicobacter Pylori-Specific Regulatory T Cells that Limit the Host Response
-
批准号:8145397
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2002
-
负责人:THOMAS G BLANCHARD
-
依托单位:
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to
-
批准号:8378490
-
项目类别:
-
资助金额:$22.6万
-
财政年份:--
-
负责人:THOMAS G BLANCHARD
-
依托单位:
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to
-
批准号:8485529
-
项目类别:
-
资助金额:$20.4万
-
财政年份:--
-
负责人:THOMAS G BLANCHARD
-
依托单位:
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to
-
批准号:8119514
-
项目类别:
-
资助金额:$27.65万
-
财政年份:--
-
负责人:THOMAS G BLANCHARD
-
依托单位:
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to
-
批准号:8282917
-
项目类别:
-
资助金额:$27.54万
-
财政年份:--
-
负责人:THOMAS G BLANCHARD
-
依托单位:
海外基金